Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors
Summary
Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors is a scholarly article[1].
Key Facts
Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors. Retrieved May 24, 2026, from https://4ort.xyz/entity/molecular-design-molecular-docking-and-admet-study-of-cyclic-sulfonamide-derivatives-as-sars-cov-2-inhibitors
MLA“Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/molecular-design-molecular-docking-and-admet-study-of-cyclic-sulfonamide-derivatives-as-sars-cov-2-inhibitors.
BibTeX@misc{4ortxyz_molecular-design-molecular-docking-and-admet-study-of-cyclic-sulfonamide-derivatives-as-sars-cov-2-inhibitors_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors}}, year = {2026}, url = {https://4ort.xyz/entity/molecular-design-molecular-docking-and-admet-study-of-cyclic-sulfonamide-derivatives-as-sars-cov-2-inhibitors}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors — https://4ort.xyz/entity/molecular-design-molecular-docking-and-admet-study-of-cyclic-sulfonamide-derivatives-as-sars-cov-2-inhibitors (retrieved 2026-05-24)
